Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Case-control study comparing the efficacy of a therapeutic combination containing the integrase inhibitor raltegravir (400 mg x 2) or a therapeutic combination not containing raltegravir on the reduction of proviral DNA in patients presenting with a pretreated HIV-1 infection with a detectable viral load [Etude cas-temoins comparant l'efficacite d'une combinaison therapeutique contenant l'inhibiteur de l'integrase raltegravir (400 mg x 2) ou une combinaison therapeutique ne contenant pas le raltegravir sur la diminution de l'ADN proviral chez des sujets pretraites presentant une infection par le VIH-1 avec une charge virale detectable]

Next Previous
Trial Profile

Case-control study comparing the efficacy of a therapeutic combination containing the integrase inhibitor raltegravir (400 mg x 2) or a therapeutic combination not containing raltegravir on the reduction of proviral DNA in patients presenting with a pretreated HIV-1 infection with a detectable viral load [Etude cas-temoins comparant l'efficacite d'une combinaison therapeutique contenant l'inhibiteur de l'integrase raltegravir (400 mg x 2) ou une combinaison therapeutique ne contenant pas le raltegravir sur la diminution de l'ADN proviral chez des sujets pretraites presentant une infection par le VIH-1 avec une charge virale detectable]

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Jun 2011

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Raltegravir (Primary)
  • Indications HIV infections
  • Focus Therapeutic Use
  • Acronyms IN-DEEP

Most Recent Events

  • 16 Jun 2011 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top